Acurx Pharmaceuticals, Inc.
|
-14.57 Million USD
|
-1843.062%
|
Adaptive Biotechnologies Corporation
|
-225.25 Million USD
|
-25.751%
|
IO Biotech, Inc.
|
-86.08 Million USD
|
-229.049%
|
VYNE Therapeutics Inc.
|
-28.45 Million USD
|
-895.554%
|
Organovo Holdings, Inc.
|
-14.67 Million USD
|
-1830.714%
|
TNF Pharmaceuticals, Inc.
|
-3.99 Million USD
|
-6981.464%
|
Lexaria Bioscience Corp.
|
-6.66 Million USD
|
-4149.952%
|
Tonix Pharmaceuticals Holding Corp.
|
-116.65 Million USD
|
-142.808%
|
Aadi Bioscience, Inc.
|
-65.76 Million USD
|
-330.708%
|
Savara Inc.
|
-54.69 Million USD
|
-417.853%
|
Aerovate Therapeutics, Inc.
|
-75.52 Million USD
|
-275.068%
|
Rocket Pharmaceuticals, Inc.
|
-245.59 Million USD
|
-15.334%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-44.6 Million USD
|
-535.054%
|
ZyVersa Therapeutics, Inc.
|
-98.29 Million USD
|
-188.16%
|
Soligenix, Inc.
|
-6.14 Million USD
|
-4512.725%
|
Aptose Biosciences Inc.
|
-51.2 Million USD
|
-453.157%
|
NKGen Biotech, Inc. Common Stock
|
-82.95 Million USD
|
-241.46%
|
Century Therapeutics, Inc.
|
-136.67 Million USD
|
-107.25%
|
Eterna Therapeutics Inc.
|
-21.66 Million USD
|
-1207.25%
|
Precision BioSciences, Inc.
|
-61.31 Million USD
|
-361.937%
|
Axsome Therapeutics, Inc.
|
-239.23 Million USD
|
-18.399%
|
Kura Oncology, Inc.
|
-152.63 Million USD
|
-85.582%
|
Xenetic Biosciences, Inc.
|
-4.13 Million USD
|
-6750.881%
|
Dyadic International, Inc.
|
-6.79 Million USD
|
-4068.297%
|
TScan Therapeutics, Inc.
|
-89.21 Million USD
|
-217.486%
|
IDEAYA Biosciences, Inc.
|
-112.96 Million USD
|
-150.755%
|
CytomX Therapeutics, Inc.
|
-569 Thousand USD
|
-49681.195%
|
Autolus Therapeutics plc
|
-208.38 Million USD
|
-35.93%
|
Eton Pharmaceuticals, Inc.
|
-936 Thousand USD
|
-30162.286%
|
EyePoint Pharmaceuticals, Inc.
|
-70.79 Million USD
|
-300.106%
|
GRI Bio, Inc.
|
-13.03 Million USD
|
-2072.701%
|
Tenaya Therapeutics, Inc.
|
-124.08 Million USD
|
-128.277%
|
IGM Biosciences, Inc.
|
-246.41 Million USD
|
-14.95%
|
Heron Therapeutics, Inc.
|
-110.55 Million USD
|
-156.203%
|
SAB Biotherapeutics, Inc.
|
-42.19 Million USD
|
-571.319%
|
Entero Therapeutics, Inc.
|
-15.79 Million USD
|
-1693.323%
|
Opthea Limited
|
-220.24 Million USD
|
-28.611%
|
X4 Pharmaceuticals, Inc.
|
-101.16 Million USD
|
-179.988%
|
Atara Biotherapeutics, Inc.
|
-276.12 Million USD
|
-2.582%
|
Pliant Therapeutics, Inc.
|
-161.33 Million USD
|
-75.568%
|
Ligand Pharmaceuticals Incorporated
|
52.15 Million USD
|
643.113%
|
Surrozen, Inc.
|
-43.04 Million USD
|
-558.09%
|
Lixte Biotechnology Holdings, Inc.
|
-5.08 Million USD
|
-5468.181%
|
Cingulate Inc.
|
-23.53 Million USD
|
-1103.551%
|
Ovid Therapeutics Inc.
|
-52.33 Million USD
|
-441.193%
|
Sorrento Therapeutics, Inc.
|
-572.84 Million USD
|
50.553%
|
Acelyrin, Inc.
|
-381.64 Million USD
|
25.78%
|
Centessa Pharmaceuticals plc
|
-151.08 Million USD
|
-87.481%
|
Hepion Pharmaceuticals, Inc.
|
-48.92 Million USD
|
-478.945%
|
Arcturus Therapeutics Holdings Inc.
|
-29.72 Million USD
|
-852.918%
|
Syros Pharmaceuticals, Inc.
|
-164.57 Million USD
|
-72.114%
|
ADMA Biologics, Inc.
|
-28.23 Million USD
|
-903.063%
|
PureTech Health plc
|
-65.69 Million USD
|
-331.154%
|
Oncternal Therapeutics, Inc.
|
-39.47 Million USD
|
-617.483%
|
FibroBiologics, Inc. Common Stock
|
-16.48 Million USD
|
-1618.259%
|
Barinthus Biotherapeutics plc
|
-73.34 Million USD
|
-286.185%
|
Kymera Therapeutics, Inc.
|
-146.96 Million USD
|
-92.74%
|
Synaptogenix, Inc.
|
-6.03 Million USD
|
-4590.814%
|
Tiziana Life Sciences Ltd
|
-16.2 Million USD
|
-1647.625%
|
ChromaDex Corporation
|
-4.93 Million USD
|
-5636.229%
|
Inhibikase Therapeutics, Inc.
|
-19.02 Million USD
|
-1388.553%
|
Monopar Therapeutics Inc.
|
-8.4 Million USD
|
-3271.202%
|
Exelixis, Inc.
|
207.76 Million USD
|
236.334%
|
Akebia Therapeutics, Inc.
|
-51.92 Million USD
|
-445.508%
|
Better Therapeutics, Inc.
|
-39.76 Million USD
|
-612.412%
|
Nurix Therapeutics, Inc.
|
-143.94 Million USD
|
-96.776%
|
Apellis Pharmaceuticals, Inc.
|
-528.62 Million USD
|
46.417%
|
Sangamo Therapeutics, Inc.
|
-257.83 Million USD
|
-9.861%
|
Seer, Inc.
|
-86.27 Million USD
|
-228.309%
|
Aridis Pharmaceuticals, Inc.
|
-30.74 Million USD
|
-821.184%
|
LAVA Therapeutics N.V.
|
-41.97 Million USD
|
-574.834%
|
Gritstone bio, Inc.
|
-138.49 Million USD
|
-104.531%
|
Jasper Therapeutics, Inc.
|
-64.46 Million USD
|
-339.393%
|
Avid Bioservices, Inc.
|
-140.75 Million USD
|
-101.243%
|
Insmed Incorporated
|
-749.56 Million USD
|
62.211%
|
Panbela Therapeutics, Inc.
|
-25.26 Million USD
|
-1021.225%
|
Avalo Therapeutics, Inc.
|
-31.54 Million USD
|
-797.968%
|
Fate Therapeutics, Inc.
|
-160.92 Million USD
|
-76.013%
|
MediWound Ltd.
|
-6.71 Million USD
|
-4117.615%
|
BioXcel Therapeutics, Inc.
|
-179.05 Million USD
|
-58.196%
|
Fortress Biotech, Inc.
|
-60.63 Million USD
|
-367.132%
|
OmniAb, Inc.
|
-50.61 Million USD
|
-459.582%
|
Seres Therapeutics, Inc.
|
-113.72 Million USD
|
-149.072%
|
Zai Lab Limited
|
-334.62 Million USD
|
15.35%
|
Revance Therapeutics, Inc.
|
-323.98 Million USD
|
12.572%
|
Tarsus Pharmaceuticals, Inc.
|
-135.89 Million USD
|
-108.44%
|
Veracyte, Inc.
|
-74.4 Million USD
|
-280.699%
|
Abeona Therapeutics Inc.
|
-54.18 Million USD
|
-422.726%
|
FibroGen, Inc.
|
-284.23 Million USD
|
0.344%
|
Apogee Therapeutics, Inc.
|
-83.98 Million USD
|
-237.269%
|
ContextLogic Inc.
|
-317 Million USD
|
10.645%
|
Intensity Therapeutics, Inc.
|
-10.53 Million USD
|
-2587.939%
|
Adial Pharmaceuticals, Inc.
|
-7 Million USD
|
-3945.408%
|
HOOKIPA Pharma Inc.
|
-81.58 Million USD
|
-247.211%
|
Jazz Pharmaceuticals plc
|
414.83 Million USD
|
168.282%
|
Entrada Therapeutics, Inc.
|
-6.68 Million USD
|
-4137.173%
|
Cyclacel Pharmaceuticals, Inc.
|
-22.55 Million USD
|
-1155.841%
|
ImmuCell Corporation
|
-5.77 Million USD
|
-4805.19%
|
Fortrea Holdings Inc.
|
-3.4 Million USD
|
-8231.029%
|
KalVista Pharmaceuticals, Inc.
|
-126.64 Million USD
|
-123.662%
|
Jasper Therapeutics, Inc.
|
-64.46 Million USD
|
-339.393%
|
Foghorn Therapeutics Inc.
|
-98.42 Million USD
|
-187.785%
|
Ultragenyx Pharmaceutical Inc.
|
-606.63 Million USD
|
53.307%
|
Theravance Biopharma, Inc.
|
-55.19 Million USD
|
-413.208%
|
Metagenomi, Inc. Common Stock
|
-68.25 Million USD
|
-314.995%
|
Vaxxinity, Inc.
|
-56.93 Thousand USD
|
-497414.666%
|
BioCryst Pharmaceuticals, Inc.
|
-226.53 Million USD
|
-25.036%
|
Gain Therapeutics, Inc.
|
-22.26 Million USD
|
-1172.055%
|
Creative Medical Technology Holdings, Inc.
|
-5.28 Million USD
|
-5258.007%
|
Marker Therapeutics, Inc.
|
-14.04 Million USD
|
-1916.639%
|
CASI Pharmaceuticals, Inc.
|
-26.93 Million USD
|
-951.507%
|
Senti Biosciences, Inc.
|
-92.91 Million USD
|
-204.841%
|
BioRestorative Therapies, Inc.
|
-10.41 Million USD
|
-2618.977%
|
Apollomics, Inc.
|
-172.6 Million USD
|
-64.11%
|
89bio, Inc.
|
-142.18 Million USD
|
-99.21%
|
Arrowhead Pharmaceuticals, Inc.
|
-205.27 Million USD
|
-37.988%
|
TransCode Therapeutics, Inc.
|
-18.54 Million USD
|
-1427.303%
|
RAPT Therapeutics, Inc.
|
-116.79 Million USD
|
-142.517%
|
Ardelyx, Inc.
|
-66.06 Million USD
|
-328.739%
|
Pluri Inc.
|
-20.88 Million USD
|
-1256.066%
|
Prothena Corporation plc
|
-147.02 Million USD
|
-92.654%
|
Pulmatrix, Inc.
|
-14.12 Million USD
|
-1905.913%
|
Celularity Inc.
|
-196.29 Million USD
|
-44.301%
|
MeiraGTx Holdings plc
|
-84.02 Million USD
|
-237.1%
|
Omeros Corporation
|
-117.81 Million USD
|
-140.428%
|
Ainos, Inc.
|
-13.77 Million USD
|
-1956.962%
|
Humacyte, Inc.
|
-110.77 Million USD
|
-155.701%
|
Mesoblast Limited
|
-87.95 Million USD
|
-222.042%
|
Cocrystal Pharma, Inc.
|
-17.98 Million USD
|
-1475.039%
|
Cidara Therapeutics, Inc.
|
-22.93 Million USD
|
-1135.249%
|
Blueprint Medicines Corporation
|
-506.98 Million USD
|
44.129%
|
Cabaletta Bio, Inc.
|
-67.67 Million USD
|
-318.552%
|
Summit Therapeutics Inc.
|
-614.92 Million USD
|
53.937%
|
Alaunos Therapeutics, Inc.
|
-35.14 Million USD
|
-706.076%
|
Scholar Rock Holding Corporation
|
-165.78 Million USD
|
-70.853%
|
Intellia Therapeutics, Inc.
|
-481.19 Million USD
|
41.135%
|
Adlai Nortye Ltd. American Depositary Shares
|
-104.87 Million USD
|
-170.099%
|
Cytokinetics, Incorporated
|
-526.24 Million USD
|
46.174%
|
Eloxx Pharmaceuticals, Inc.
|
-36.06 Million USD
|
-685.401%
|
Nutriband Inc.
|
-5.48 Million USD
|
-5063.879%
|
Protara Therapeutics, Inc.
|
-40.42 Million USD
|
-600.779%
|
Roivant Sciences Ltd.
|
4.34 Billion USD
|
106.513%
|
Evogene Ltd.
|
-23.87 Million USD
|
-1086.21%
|
Applied Therapeutics, Inc.
|
-119.76 Million USD
|
-136.513%
|
Hoth Therapeutics, Inc.
|
-7.84 Million USD
|
-3510.464%
|
BridgeBio Pharma, Inc.
|
-643.2 Million USD
|
55.962%
|
BioLineRx Ltd.
|
-60.61 Million USD
|
-367.31%
|
Atai Life Sciences N.V.
|
-40.22 Million USD
|
-604.194%
|
VistaGen Therapeutics, Inc.
|
-29.36 Million USD
|
-864.699%
|
Aurinia Pharmaceuticals Inc.
|
-78.02 Million USD
|
-263.054%
|
MediciNova, Inc.
|
-8.57 Million USD
|
-3204.608%
|
Praxis Precision Medicines, Inc.
|
-123.27 Million USD
|
-129.771%
|
MiMedx Group, Inc.
|
67.43 Million USD
|
520.017%
|
PTC Therapeutics, Inc.
|
-626.6 Million USD
|
54.795%
|
Cullinan Oncology, Inc.
|
-153.16 Million USD
|
-84.938%
|
Syndax Pharmaceuticals, Inc.
|
-209.36 Million USD
|
-35.296%
|
Pasithea Therapeutics Corp.
|
-15.96 Million USD
|
-1674.596%
|
NRx Pharmaceuticals, Inc.
|
-30.15 Million USD
|
-839.486%
|
4D Molecular Therapeutics, Inc.
|
-100.83 Million USD
|
-180.904%
|
Dyne Therapeutics, Inc.
|
-235.93 Million USD
|
-20.055%
|
Kiniksa Pharmaceuticals, Ltd.
|
14.08 Million USD
|
2111.183%
|
Ventyx Biosciences, Inc.
|
-192.96 Million USD
|
-46.793%
|
Allakos Inc.
|
-185.7 Million USD
|
-52.533%
|
Fulcrum Therapeutics, Inc.
|
-97.33 Million USD
|
-191.01%
|
Corcept Therapeutics Incorporated
|
106.14 Million USD
|
366.869%
|
BioAtla, Inc.
|
-123.46 Million USD
|
-129.427%
|
Allogene Therapeutics, Inc.
|
-327.26 Million USD
|
13.448%
|
Larimar Therapeutics, Inc.
|
-36.94 Million USD
|
-666.611%
|
Precigen, Inc.
|
-95.9 Million USD
|
-195.353%
|
BriaCell Therapeutics Corp.
|
-4.79 Million USD
|
-5811.656%
|
XOMA Corporation
|
-40.83 Million USD
|
-593.725%
|
Kezar Life Sciences, Inc.
|
-101.87 Million USD
|
-178.055%
|
Incyte Corporation
|
597.59 Million USD
|
147.399%
|
Cara Therapeutics, Inc.
|
-118.51 Million USD
|
-139.008%
|
Aligos Therapeutics, Inc.
|
-87.67 Million USD
|
-223.059%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-24.33 Million USD
|
-1063.777%
|
CRISPR Therapeutics AG
|
-153.61 Million USD
|
-84.399%
|
Akero Therapeutics, Inc.
|
-151.75 Million USD
|
-86.648%
|
Eliem Therapeutics, Inc.
|
-35.11 Million USD
|
-706.558%
|
EyeGate Pharmaceuticals, Inc.
|
-8.09 Million USD
|
-3400.458%
|
UroGen Pharma Ltd.
|
-102.24 Million USD
|
-177.038%
|
Sutro Biopharma, Inc.
|
-106.79 Million USD
|
-165.237%
|
ZIVO Bioscience, Inc.
|
-7.77 Million USD
|
-3542.128%
|
Lisata Therapeutics, Inc.
|
-20.84 Million USD
|
-1259.189%
|
Stoke Therapeutics, Inc.
|
-104.69 Million USD
|
-170.542%
|
Chimerix, Inc.
|
-82.09 Million USD
|
-245.033%
|
Outlook Therapeutics, Inc.
|
-58.98 Million USD
|
-380.234%
|
60 Degrees Pharmaceuticals, Inc.
|
-3.76 Million USD
|
-7421.971%
|
Enanta Pharmaceuticals, Inc.
|
-133.81 Million USD
|
-111.675%
|
Aprea Therapeutics, Inc.
|
-14.28 Million USD
|
-1882.64%
|
Portage Biotech Inc.
|
-75.33 Million USD
|
-275.974%
|
OncoCyte Corporation
|
-27.78 Million USD
|
-919.6%
|
Qualigen Therapeutics, Inc.
|
-13.41 Million USD
|
-2011.132%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-8.35 Million USD
|
-3289.399%
|
Processa Pharmaceuticals, Inc.
|
-11.12 Million USD
|
-2446.909%
|
Purple Biotech Ltd.
|
-19.88 Million USD
|
-1324.824%
|
NextCure, Inc.
|
-62.72 Million USD
|
-351.597%
|
ProMIS Neurosciences, Inc.
|
-17.5 Million USD
|
-1518.032%
|
Dermata Therapeutics, Inc.
|
-7.79 Million USD
|
-3533.948%
|
Generation Bio Co.
|
-126.61 Million USD
|
-123.719%
|
Neumora Therapeutics, Inc. Common Stock
|
-235.92 Million USD
|
-20.061%
|
Xeris Biopharma Holdings, Inc.
|
-62.25 Million USD
|
-354.992%
|
TRACON Pharmaceuticals, Inc.
|
-3.58 Million USD
|
-7794.509%
|
NLS Pharmaceutics AG
|
-12.17 Million USD
|
-2227.098%
|
Mineralys Therapeutics, Inc.
|
-71.89 Million USD
|
-293.968%
|
Novavax, Inc.
|
-545.06 Million USD
|
48.033%
|
Virios Therapeutics, Inc.
|
-5.29 Million USD
|
-5248.455%
|
Curis, Inc.
|
-47.41 Million USD
|
-497.421%
|
Daré Bioscience, Inc.
|
-30.16 Million USD
|
-839.131%
|
Titan Pharmaceuticals, Inc.
|
-5.56 Million USD
|
-4986.281%
|
Virpax Pharmaceuticals, Inc.
|
-15.18 Million USD
|
-1764.807%
|
Bicycle Therapeutics plc
|
-180.66 Million USD
|
-56.786%
|
BeiGene, Ltd.
|
-881.7 Million USD
|
67.874%
|
Kiromic BioPharma, Inc.
|
-21.29 Million USD
|
-1230.21%
|
Alector, Inc.
|
-130.39 Million USD
|
-117.235%
|
Protagonist Therapeutics, Inc.
|
-78.95 Million USD
|
-258.755%
|
Erasca, Inc.
|
-125.04 Million USD
|
-126.528%
|
Checkpoint Therapeutics, Inc.
|
-51.84 Million USD
|
-446.329%
|
Aura Biosciences, Inc.
|
-76.4 Million USD
|
-270.714%
|
Viracta Therapeutics, Inc.
|
-51.05 Million USD
|
-454.771%
|
Chemomab Therapeutics Ltd.
|
-24.22 Million USD
|
-1069.46%
|
Protagenic Therapeutics, Inc.
|
-5 Million USD
|
-5564.537%
|
Pieris Pharmaceuticals, Inc.
|
-24.54 Million USD
|
-1054.117%
|
BioMarin Pharmaceutical Inc.
|
167.64 Million USD
|
268.961%
|
Histogen Inc.
|
-10.62 Million USD
|
-2566.933%
|
Fortress Biotech, Inc.
|
-60.63 Million USD
|
-367.132%
|
Avidity Biosciences, Inc.
|
-212.22 Million USD
|
-33.472%
|
Lyell Immunopharma, Inc.
|
-234.63 Million USD
|
-20.723%
|
Galecto, Inc.
|
-38.34 Million USD
|
-638.624%
|
InMed Pharmaceuticals Inc.
|
-7.67 Million USD
|
-3590.354%
|
Phathom Pharmaceuticals, Inc.
|
-201.59 Million USD
|
-40.509%
|
Molecular Templates, Inc.
|
-8.12 Million USD
|
-3386.645%
|
PDS Biotechnology Corporation
|
-42.94 Million USD
|
-559.619%
|
Amylyx Pharmaceuticals, Inc.
|
49.27 Million USD
|
674.892%
|
Amarin Corporation plc
|
-59.11 Million USD
|
-379.184%
|
TG Therapeutics, Inc.
|
12.67 Million USD
|
2335.283%
|
Aptevo Therapeutics Inc.
|
-17.41 Million USD
|
-1526.874%
|
Celldex Therapeutics, Inc.
|
-141.42 Million USD
|
-100.281%
|
Cogent Biosciences, Inc.
|
-192.41 Million USD
|
-47.214%
|
Onconetix, Inc.
|
-37.4 Million USD
|
-657.17%
|
MacroGenics, Inc.
|
-9.05 Million USD
|
-3027.125%
|
Y-mAbs Therapeutics, Inc.
|
-21.42 Million USD
|
-1221.954%
|
Ocuphire Pharma, Inc.
|
-9.98 Million USD
|
-2736.521%
|
Adagene Inc.
|
-18.94 Million USD
|
-1395.036%
|
Inhibrx Biosciences, Inc.
|
-241.36 Million USD
|
-17.357%
|
Cartesian Therapeutics, Inc.
|
-219.71 Million USD
|
-28.922%
|
Voyager Therapeutics, Inc.
|
132.33 Million USD
|
314.052%
|
SciSparc Ltd.
|
-5.12 Million USD
|
-5430.164%
|
Revelation Biosciences, Inc.
|
-120.25 Thousand USD
|
-235447.258%
|
Minerva Neurosciences, Inc.
|
-30 Million USD
|
-844.015%
|
Astria Therapeutics, Inc.
|
-72.89 Million USD
|
-288.601%
|
Black Diamond Therapeutics, Inc.
|
-82.44 Million USD
|
-243.581%
|
Arcutis Biotherapeutics, Inc.
|
-262.14 Million USD
|
-8.055%
|
Relay Therapeutics, Inc.
|
-341.97 Million USD
|
17.17%
|
Alnylam Pharmaceuticals, Inc.
|
-440.24 Million USD
|
35.659%
|
Psyence Biomedical Ltd.
|
-51.15 Million USD
|
-453.675%
|
Artelo Biosciences, Inc.
|
-9.87 Million USD
|
-2768.696%
|
2seventy bio, Inc.
|
-217.57 Million USD
|
-30.19%
|
Clene Inc.
|
-49.5 Million USD
|
-472.186%
|
Boundless Bio, Inc. Common Stock
|
-49.43 Million USD
|
-472.996%
|
GeoVax Labs, Inc.
|
-25.96 Million USD
|
-990.837%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.83 Million USD
|
-1404.06%
|
Arbutus Biopharma Corporation
|
-72.84 Million USD
|
-288.825%
|
Scopus BioPharma Inc.
|
-11.6 Million USD
|
-2339.787%
|
Absci Corporation
|
-110.56 Million USD
|
-156.186%
|
XBiotech Inc.
|
-24.55 Million USD
|
-1053.459%
|
ALX Oncology Holdings Inc.
|
-160.8 Million USD
|
-76.148%
|
Lyra Therapeutics, Inc.
|
-62.68 Million USD
|
-351.907%
|
Entera Bio Ltd.
|
-8.88 Million USD
|
-3086.579%
|
Trevena, Inc.
|
-40.28 Million USD
|
-603.058%
|
Adaptimmune Therapeutics plc
|
-113.87 Million USD
|
-148.751%
|
Caribou Biosciences, Inc.
|
-102.07 Million USD
|
-177.511%
|
INmune Bio, Inc.
|
-30 Million USD
|
-843.932%
|
Citius Pharmaceuticals, Inc.
|
-32.54 Million USD
|
-770.405%
|
Tyra Biosciences, Inc.
|
-69.13 Million USD
|
-309.719%
|
Galmed Pharmaceuticals Ltd.
|
-6.91 Million USD
|
-3998.018%
|
Unity Biotechnology, Inc.
|
-39.86 Million USD
|
-610.625%
|
Tenax Therapeutics, Inc.
|
-7.71 Million USD
|
-3573.544%
|
Jaguar Health, Inc.
|
-41.3 Million USD
|
-585.847%
|
Clearside Biomedical, Inc.
|
-32.48 Million USD
|
-771.956%
|
NexImmune, Inc.
|
-32.34 Million USD
|
-775.747%
|
Connect Biopharma Holdings Limited
|
-59.5 Million USD
|
-376.035%
|
Clearmind Medicine Inc.
|
-11.95 Million USD
|
-2269.337%
|
Coeptis Therapeutics Holdings, Inc.
|
-21.26 Million USD
|
-1231.928%
|
Kronos Bio, Inc.
|
-112.67 Million USD
|
-151.396%
|
Innoviva, Inc.
|
179.72 Million USD
|
257.607%
|
Coherus BioSciences, Inc.
|
-237.89 Million USD
|
-19.069%
|
Regeneron Pharmaceuticals, Inc.
|
3.95 Billion USD
|
107.164%
|
Bolt Biotherapeutics, Inc.
|
-69.19 Million USD
|
-309.346%
|
Verastem, Inc.
|
-87.36 Million USD
|
-224.213%
|
ProKidney Corp.
|
-35.46 Million USD
|
-698.621%
|
CERo Therapeutics Holdings, Inc.
|
-2536.23 USD
|
-11168248.296%
|
Imunon, Inc.
|
-19.51 Million USD
|
-1351.475%
|
Viking Therapeutics, Inc.
|
-85.89 Million USD
|
-229.769%
|
Statera Biopharma, Inc.
|
-174.4 Million USD
|
-62.409%
|
ImmunityBio, Inc.
|
-583.19 Million USD
|
51.431%
|
Korro Bio, Inc.
|
-81.17 Million USD
|
-248.957%
|
Travere Therapeutics, Inc.
|
-111.39 Million USD
|
-154.271%
|
Kineta, Inc.
|
-14.09 Million USD
|
-1909.043%
|
Catalyst Pharmaceuticals, Inc.
|
71.41 Million USD
|
496.66%
|
Capricor Therapeutics, Inc.
|
-22.28 Million USD
|
-1170.912%
|
GT Biopharma, Inc.
|
-7.59 Million USD
|
-3628.511%
|
Keros Therapeutics, Inc.
|
-152.99 Million USD
|
-85.144%
|
Celularity Inc.
|
-196.29 Million USD
|
-44.301%
|
Crinetics Pharmaceuticals, Inc.
|
-214.52 Million USD
|
-32.036%
|
CalciMedica, Inc.
|
-34.35 Million USD
|
-724.446%
|
Cibus, Inc.
|
-267.62 Million USD
|
-5.839%
|
C4 Therapeutics, Inc.
|
-132.49 Million USD
|
-113.789%
|
Marinus Pharmaceuticals, Inc.
|
-141.4 Million USD
|
-100.315%
|
Eledon Pharmaceuticals, Inc.
|
-40.32 Million USD
|
-602.413%
|
Kodiak Sciences Inc.
|
-260.49 Million USD
|
-8.739%
|
Annexon, Inc.
|
-134.23 Million USD
|
-111.011%
|
Adverum Biotechnologies, Inc.
|
-117.16 Million USD
|
-141.757%
|
Assembly Biosciences, Inc.
|
-61.22 Million USD
|
-362.623%
|
Elicio Therapeutics, Inc.
|
-35.19 Million USD
|
-704.816%
|
Moderna, Inc.
|
-4.71 Billion USD
|
93.991%
|
Vigil Neuroscience, Inc.
|
-82.63 Million USD
|
-242.766%
|
Ionis Pharmaceuticals, Inc.
|
-366.28 Million USD
|
22.668%
|
Vor Biopharma Inc.
|
-117.86 Million USD
|
-140.326%
|
Eyenovia, Inc.
|
-27.26 Million USD
|
-939.045%
|
DiaMedica Therapeutics Inc.
|
-19.38 Million USD
|
-1361.509%
|
Puma Biotechnology, Inc.
|
21.59 Million USD
|
1411.912%
|
Monte Rosa Therapeutics, Inc.
|
-135.35 Million USD
|
-109.273%
|
Wave Life Sciences Ltd.
|
-57.51 Million USD
|
-392.506%
|
Conduit Pharmaceuticals Inc.
|
-535 Thousand USD
|
-52844.86%
|
ACADIA Pharmaceuticals Inc.
|
-61.28 Million USD
|
-362.185%
|
Immunocore Holdings plc
|
-55.28 Million USD
|
-412.336%
|
Tango Therapeutics, Inc.
|
-101.74 Million USD
|
-178.4%
|
Galectin Therapeutics Inc.
|
-41.06 Million USD
|
-589.756%
|
Alkermes plc
|
355.75 Million USD
|
179.62%
|
Arcellx, Inc.
|
-70.69 Million USD
|
-300.7%
|
Renovaro Biosciences Inc.
|
-80.65 Million USD
|
-251.214%
|
Zentalis Pharmaceuticals, Inc.
|
-292.19 Million USD
|
3.058%
|
Sagimet Biosciences Inc.
|
-27.87 Million USD
|
-916.125%
|
Regulus Therapeutics Inc.
|
-30.03 Million USD
|
-843.02%
|
Cardio Diagnostics Holdings, Inc.
|
-8.37 Million USD
|
-3281.409%
|
Moolec Science SA
|
-51.78 Million USD
|
-446.942%
|
Biomea Fusion, Inc.
|
-117.25 Million USD
|
-141.572%
|
RenovoRx, Inc.
|
-10.23 Million USD
|
-2668.325%
|
Geron Corporation
|
-184.12 Million USD
|
-53.837%
|
Mereo BioPharma Group plc
|
-29.46 Million USD
|
-861.294%
|
Verrica Pharmaceuticals Inc.
|
-66.99 Million USD
|
-322.8%
|
Royalty Pharma plc
|
1.13 Billion USD
|
124.96%
|
Atea Pharmaceuticals, Inc.
|
-135.95 Million USD
|
-108.343%
|
Greenwich LifeSciences, Inc.
|
-8.89 Million USD
|
-3085.574%
|
Calithera Biosciences, Inc.
|
-18.86 Million USD
|
-1401.405%
|
TFF Pharmaceuticals, Inc.
|
-21.24 Million USD
|
-1233.389%
|
Mersana Therapeutics, Inc.
|
-171.67 Million USD
|
-65.0%
|
Humacyte, Inc.
|
-110.77 Million USD
|
-155.701%
|
Structure Therapeutics Inc.
|
-89.62 Million USD
|
-216.062%
|
NLS Pharmaceutics AG
|
-12.17 Million USD
|
-2227.098%
|
Genelux Corporation
|
-28.29 Million USD
|
-901.007%
|
ESSA Pharma Inc.
|
-26.58 Million USD
|
-965.576%
|
aTyr Pharma, Inc.
|
-50.38 Million USD
|
-462.137%
|
Notable Labs, Ltd.
|
-11.26 Million USD
|
-2414.693%
|
Alzamend Neuro, Inc.
|
-9.94 Million USD
|
-2747.429%
|
Mustang Bio, Inc.
|
-51.6 Million USD
|
-448.923%
|
Immunovant, Inc.
|
-259.33 Million USD
|
-9.223%
|
Tevogen Bio Holdings Inc.
|
-67.32 Thousand USD
|
-420627.813%
|
Vericel Corporation
|
-3.18 Million USD
|
-8801.791%
|
Halozyme Therapeutics, Inc.
|
281.59 Million USD
|
200.59%
|
Akari Therapeutics, Plc
|
-10 Million USD
|
-2730.286%
|
Acasti Pharma Inc.
|
-12.85 Million USD
|
-2103.805%
|
MiNK Therapeutics, Inc.
|
-22.45 Million USD
|
-1161.273%
|
Vaxcyte, Inc.
|
-402.26 Million USD
|
29.585%
|
Orgenesis Inc.
|
-55.36 Million USD
|
-411.651%
|
Spruce Biosciences, Inc.
|
-47.91 Million USD
|
-491.112%
|
NeuroBo Pharmaceuticals, Inc.
|
-12.47 Million USD
|
-2171.492%
|
GH Research PLC
|
-35.58 Million USD
|
-695.951%
|
Tempest Therapeutics, Inc.
|
-29.49 Million USD
|
-860.479%
|
PepGen Inc.
|
-78.62 Million USD
|
-260.256%
|
Moleculin Biotech, Inc.
|
-29.76 Million USD
|
-851.51%
|
Relmada Therapeutics, Inc.
|
-98.79 Million USD
|
-186.719%
|
BriaCell Therapeutics Corp.
|
-4.79 Million USD
|
-5811.656%
|
Lixte Biotechnology Holdings, Inc.
|
-5.08 Million USD
|
-5468.181%
|
Silo Pharma, Inc.
|
-3.7 Million USD
|
-7554.128%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-13.07 Million USD
|
-2066.906%
|
Belite Bio, Inc
|
-31.63 Million USD
|
-795.47%
|
Pharming Group N.V.
|
-10.54 Million USD
|
-2585.391%
|
XOMA Corporation
|
-40.83 Million USD
|
-593.725%
|
Reneo Pharmaceuticals, Inc.
|
-77.38 Million USD
|
-266.019%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-24.33 Million USD
|
-1063.777%
|
Bionomics Limited
|
-15.49 Billion USD
|
98.172%
|
Xencor, Inc.
|
-126.08 Million USD
|
-124.65%
|
Replimune Group, Inc.
|
-215.79 Million USD
|
-31.262%
|
Pyxis Oncology, Inc.
|
-73.79 Million USD
|
-283.866%
|
Cassava Sciences, Inc.
|
-97.21 Million USD
|
-191.364%
|
Vanda Pharmaceuticals Inc.
|
2.5 Million USD
|
11389.558%
|
Estrella Immunopharma, Inc.
|
-7.31 Million USD
|
-3773.984%
|
Turnstone Biologics Corp.
|
-55.2 Million USD
|
-413.143%
|
Windtree Therapeutics, Inc.
|
-20.29 Million USD
|
-1295.964%
|
GeoVax Labs, Inc.
|
-25.96 Million USD
|
-990.837%
|
MEI Pharma, Inc.
|
17.77 Million USD
|
1693.289%
|
Olema Pharmaceuticals, Inc.
|
-96.65 Million USD
|
-193.058%
|
Cardio Diagnostics Holdings, Inc.
|
-8.37 Million USD
|
-3281.409%
|
Bio-Path Holdings, Inc.
|
-16.07 Million USD
|
-1661.755%
|
Enlivex Therapeutics Ltd.
|
-29.06 Million USD
|
-874.456%
|
CollPlant Biotechnologies Ltd.
|
-7.01 Million USD
|
-3935.546%
|
scPharmaceuticals Inc.
|
-54.81 Million USD
|
-416.794%
|
HilleVax, Inc.
|
-123.56 Million USD
|
-129.234%
|
Vera Therapeutics, Inc.
|
-95.99 Million USD
|
-195.088%
|
Tharimmune, Inc.
|
-9.31 Million USD
|
-2939.512%
|
Genprex, Inc.
|
-30.86 Million USD
|
-817.857%
|
SeaStar Medical Holding Corporation
|
-26.23 Million USD
|
-979.807%
|
Immunic, Inc.
|
-93.61 Million USD
|
-202.584%
|
Atossa Therapeutics, Inc.
|
-30.09 Million USD
|
-841.234%
|
Aptorum Group Limited
|
-2.82 Million USD
|
-9927.979%
|
Soleno Therapeutics, Inc.
|
-38.98 Million USD
|
-626.518%
|
SeaStar Medical Holding Corporation
|
-26.23 Million USD
|
-979.807%
|
OKYO Pharma Limited
|
-16.82 Thousand USD
|
-1683390.377%
|
Carmell Therapeutics Corporation
|
-15.44 Million USD
|
-1733.949%
|
Achieve Life Sciences, Inc.
|
-29.81 Million USD
|
-850.042%
|
Ocean Biomedical, Inc.
|
565.47 Thousand USD
|
50191.959%
|
Amicus Therapeutics, Inc.
|
-151.58 Million USD
|
-86.863%
|
Salarius Pharmaceuticals, Inc.
|
-12.54 Thousand USD
|
-2258227.36%
|
bluebird bio, Inc.
|
-211.91 Million USD
|
-33.666%
|
DBV Technologies S.A.
|
-72.72 Million USD
|
-289.482%
|
Compugen Ltd.
|
-18.75 Million USD
|
-1410.371%
|
Protagenic Therapeutics, Inc.
|
-5 Million USD
|
-5564.537%
|
Peak Bio, Inc.
|
-1259.26 USD
|
-22493666.18%
|
Vincerx Pharma, Inc.
|
-40.15 Million USD
|
-605.369%
|
Fresh Tracks Therapeutics, Inc.
|
-5.69 Million USD
|
-4874.622%
|
Sensei Biotherapeutics, Inc.
|
-34.1 Million USD
|
-730.635%
|
Orchestra BioMed Holdings, Inc.
|
-49.12 Million USD
|
-476.659%
|
Zevra Therapeutics, Inc.
|
-46.04 Million USD
|
-515.117%
|
Acrivon Therapeutics, Inc. Common Stock
|
-60.38 Million USD
|
-369.058%
|
Benitec Biopharma Inc.
|
-21.75 Million USD
|
-1202.262%
|
Spyre Therapeutics, Inc.
|
-338.79 Million USD
|
16.392%
|
Adicet Bio, Inc.
|
-142.65 Million USD
|
-98.555%
|
Prime Medicine, Inc.
|
-198.13 Million USD
|
-42.962%
|
Aditxt, Inc.
|
-32.38 Million USD
|
-774.761%
|
Madrigal Pharmaceuticals, Inc.
|
-373.63 Million USD
|
24.188%
|
Estrella Immunopharma, Inc.
|
-7.31 Million USD
|
-3773.984%
|
Quantum-Si incorporated
|
-95.96 Million USD
|
-195.18%
|
GlycoMimetics, Inc.
|
-36.89 Million USD
|
-667.641%
|
PolyPid Ltd.
|
-23.86 Million USD
|
-1086.906%
|
Aileron Therapeutics, Inc.
|
-15.73 Million USD
|
-1700.502%
|
Invivyd, Inc.
|
-198.64 Million USD
|
-42.595%
|
Quoin Pharmaceuticals, Ltd.
|
-8.68 Million USD
|
-3160.837%
|
Rigel Pharmaceuticals, Inc.
|
-25.09 Million USD
|
-1028.911%
|
CorMedix Inc.
|
-46.33 Million USD
|
-511.264%
|
Instil Bio, Inc.
|
-156.08 Million USD
|
-81.473%
|
Recursion Pharmaceuticals, Inc.
|
-328.06 Million USD
|
13.659%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
22.72 Million USD
|
1346.721%
|
Finch Therapeutics Group, Inc.
|
-74.75 Million USD
|
-278.916%
|
Spero Therapeutics, Inc.
|
22.8 Million USD
|
1342.02%
|
Alpha Tau Medical Ltd.
|
-29.15 Million USD
|
-871.482%
|
AbCellera Biologics Inc.
|
-146.39 Million USD
|
-93.483%
|
Ocular Therapeutix, Inc.
|
-80.73 Million USD
|
-250.841%
|
Surrozen, Inc.
|
-43.04 Million USD
|
-558.09%
|
Janux Therapeutics, Inc.
|
-58.29 Million USD
|
-385.916%
|
Verona Pharma plc
|
-54.36 Million USD
|
-420.986%
|
Terns Pharmaceuticals, Inc.
|
-90.21 Million USD
|
-213.995%
|
Vir Biotechnology, Inc.
|
-615.06 Million USD
|
53.947%
|
Evaxion Biotech A/S
|
-22.12 Million USD
|
-1180.249%
|
Verve Therapeutics, Inc.
|
-200.06 Million USD
|
-41.579%
|
Shattuck Labs, Inc.
|
-87.29 Million USD
|
-224.469%
|
AlloVir, Inc.
|
-190.41 Million USD
|
-48.754%
|
BioVie Inc.
|
-32.12 Million USD
|
-781.85%
|
Codexis, Inc.
|
-76.24 Million USD
|
-271.531%
|
SELLAS Life Sciences Group, Inc.
|
-37.34 Million USD
|
-658.583%
|
Lexaria Bioscience Corp.
|
-6.66 Million USD
|
-4149.952%
|
Agenus Inc.
|
-245.76 Million USD
|
-15.256%
|
Virax Biolabs Group Limited
|
-6.73 Million USD
|
-4106.63%
|
Lantern Pharma Inc.
|
-15.96 Million USD
|
-1674.61%
|
Viridian Therapeutics, Inc.
|
-237.73 Million USD
|
-19.148%
|
eFFECTOR Therapeutics, Inc.
|
-35.81 Million USD
|
-690.972%
|
Immix Biopharma, Inc.
|
-15.42 Million USD
|
-1736.212%
|
Celcuity Inc.
|
-63.77 Million USD
|
-344.119%
|
Cardiff Oncology, Inc.
|
-41.44 Million USD
|
-583.514%
|
Acumen Pharmaceuticals, Inc.
|
-52.37 Million USD
|
-440.862%
|
IN8bio, Inc.
|
-30 Million USD
|
-843.963%
|
Avenue Therapeutics, Inc.
|
-10.37 Million USD
|
-2629.642%
|
Trevi Therapeutics, Inc.
|
-29.06 Million USD
|
-874.557%
|
Lexicon Pharmaceuticals, Inc.
|
-177.11 Million USD
|
-59.924%
|
Liquidia Corporation
|
-78.5 Million USD
|
-260.825%
|
Quantum-Si incorporated
|
-95.96 Million USD
|
-195.18%
|
Pasithea Therapeutics Corp.
|
-15.96 Million USD
|
-1674.596%
|
Xenon Pharmaceuticals Inc.
|
-182.39 Million USD
|
-55.299%
|
Sol-Gel Technologies Ltd.
|
-27.23 Million USD
|
-939.926%
|
United Therapeutics Corporation
|
984.8 Million USD
|
128.763%
|
Solid Biosciences Inc.
|
-96.01 Million USD
|
-195.011%
|
Immuneering Corporation
|
-53.47 Million USD
|
-429.73%
|
Alpha Tau Medical Ltd.
|
-29.15 Million USD
|
-871.482%
|
uniQure N.V.
|
-308.47 Million USD
|
8.177%
|
Xilio Therapeutics, Inc.
|
-76.4 Million USD
|
-270.733%
|
Enveric Biosciences, Inc.
|
-17.29 Thousand USD
|
-1637995.205%
|
Poseida Therapeutics, Inc.
|
-123.43 Million USD
|
-129.486%
|
Longboard Pharmaceuticals, Inc.
|
-54.42 Million USD
|
-420.479%
|
PMV Pharmaceuticals, Inc.
|
-68.96 Million USD
|
-310.753%
|
Elevai Labs, Inc. Common Stock
|
-4.3 Million USD
|
-6485.002%
|
Cue Biopharma, Inc.
|
-50.73 Million USD
|
-458.325%
|
Nuvectis Pharma, Inc.
|
-22.26 Million USD
|
-1172.484%
|
ARS Pharmaceuticals, Inc.
|
-54.36 Million USD
|
-421.025%
|
Zura Bio Limited
|
-60.36 Million USD
|
-369.276%
|
Forte Biosciences, Inc.
|
-31.47 Million USD
|
-799.908%
|
Elevation Oncology, Inc.
|
-45.7 Million USD
|
-519.76%
|
Conduit Pharmaceuticals Inc.
|
-535 Thousand USD
|
-52844.86%
|
Immunome, Inc.
|
-106.8 Million USD
|
-165.205%
|
Compass Therapeutics, Inc.
|
-42.49 Million USD
|
-566.576%
|
enGene Holdings Inc. Warrants
|
-99.91 Million USD
|
-183.49%
|
Inovio Pharmaceuticals, Inc.
|
-135.11 Million USD
|
-109.636%
|
LENZ Therapeutics, Inc.
|
-124.65 Million USD
|
-127.238%
|
Altimmune, Inc.
|
-88.44 Million USD
|
-220.254%
|
Milestone Pharmaceuticals Inc.
|
-59.68 Million USD
|
-374.583%
|
Rallybio Corporation
|
-74.56 Million USD
|
-279.882%
|
Plus Therapeutics, Inc.
|
-13.31 Million USD
|
-2027.178%
|
Dianthus Therapeutics, Inc.
|
-43.55 Million USD
|
-550.339%
|
Moolec Science SA
|
-51.78 Million USD
|
-446.942%
|
Anebulo Pharmaceuticals, Inc.
|
-8.2 Million USD
|
-3353.612%
|
XTL Biopharmaceuticals Ltd.
|
-1.78 Million USD
|
-15795.342%
|
Tourmaline Bio, Inc.
|
-42.12 Million USD
|
-572.431%
|
NeurAxis, Inc.
|
-14.62 Million USD
|
-1836.563%
|
Maravai LifeSciences Holdings, Inc.
|
-119.02 Million USD
|
-137.971%
|
Lumos Pharma, Inc.
|
-34.03 Million USD
|
-732.271%
|
enGene Holdings Inc. Common Stock
|
-99.91 Million USD
|
-183.49%
|
180 Life Sciences Corp.
|
-19.93 Million USD
|
-1320.885%
|
NKGen Biotech, Inc. Warrants
|
-82.95 Million USD
|
-241.46%
|
Opiant Pharmaceuticals, Inc.
|
3 Million USD
|
9514.25%
|
CERo Therapeutics Holdings, Inc.
|
-2536.23 USD
|
-11168248.296%
|
Nutriband Inc.
|
-5.48 Million USD
|
-5063.879%
|
CG Oncology, Inc. Common stock
|
-48.6 Million USD
|
-482.745%
|
argenx SE
|
-295.05 Million USD
|
3.999%
|
Neurogene Inc.
|
-36.31 Million USD
|
-679.952%
|
Mirum Pharmaceuticals, Inc.
|
-163.41 Million USD
|
-73.335%
|
Kintara Therapeutics, Inc.
|
-8.5 Million USD
|
-3232.02%
|
CervoMed Inc.
|
-2.17 Million USD
|
-12941.969%
|
CARGO Therapeutics, Inc. Common Stock
|
-98.14 Million USD
|
-188.603%
|
Sesen Bio, Inc.
|
-19.88 Million USD
|
-1324.537%
|
AnaptysBio, Inc.
|
-163.61 Million USD
|
-73.119%
|
Design Therapeutics, Inc.
|
-66.86 Million USD
|
-323.641%
|
Leap Therapeutics, Inc.
|
-81.41 Million USD
|
-247.919%
|
Seelos Therapeutics, Inc.
|
-37.88 Million USD
|
-647.73%
|
Achilles Therapeutics plc
|
-69.66 Million USD
|
-306.596%
|
NeuroSense Therapeutics Ltd.
|
-10.1 Million USD
|
-2702.563%
|
ORIC Pharmaceuticals, Inc.
|
-100.69 Million USD
|
-181.294%
|
Fractyl Health, Inc. Common Stock
|
-77.09 Million USD
|
-267.429%
|
Rani Therapeutics Holdings, Inc.
|
-33.97 Million USD
|
-733.839%
|
MoonLake Immunotherapeutics
|
-36 Million USD
|
-686.661%
|
Palisade Bio, Inc.
|
-12.3 Million USD
|
-2202.886%
|
Beam Therapeutics Inc.
|
-132.52 Million USD
|
-113.734%
|
AEON Biopharma, Inc.
|
-52.55 Million USD
|
-438.958%
|
Enliven Therapeutics, Inc.
|
-71.58 Million USD
|
-295.696%
|
Kiora Pharmaceuticals, Inc.
|
-12.51 Million USD
|
-2163.524%
|
Iovance Biotherapeutics, Inc.
|
-444.03 Million USD
|
36.209%
|
Taysha Gene Therapies, Inc.
|
-111.56 Million USD
|
-153.89%
|
Athira Pharma, Inc.
|
-117.67 Million USD
|
-140.716%
|
Vaccinex, Inc.
|
-20.25 Million USD
|
-1298.721%
|
HCW Biologics Inc.
|
-24.99 Million USD
|
-1033.279%
|
XOMA Corporation
|
-40.83 Million USD
|
-593.725%
|
Nektar Therapeutics
|
-276.05 Million USD
|
-2.608%
|
Arvinas, Inc.
|
-367.3 Million USD
|
22.882%
|
Tevogen Bio Holdings Inc.
|
-67.32 Thousand USD
|
-420627.813%
|
Merus N.V.
|
-154.93 Million USD
|
-82.817%
|
Omega Therapeutics, Inc.
|
-97.42 Million USD
|
-190.733%
|
Quince Therapeutics, Inc.
|
-31.38 Million USD
|
-802.517%
|
Rezolute, Inc.
|
-68.45 Million USD
|
-313.759%
|
Clene Inc.
|
-49.5 Million USD
|
-472.186%
|
Indaptus Therapeutics, Inc.
|
-15.42 Million USD
|
-1736.519%
|
BeyondSpring Inc.
|
-21.02 Million USD
|
-1247.165%
|
Synlogic, Inc.
|
-57.28 Million USD
|
-394.492%
|
Allarity Therapeutics, Inc.
|
-11.9 Million USD
|
-2280.094%
|
Phio Pharmaceuticals Corp.
|
-10.82 Million USD
|
-2516.433%
|
Peak Bio, Inc.
|
-1259.26 USD
|
-22493666.18%
|
Werewolf Therapeutics, Inc.
|
-37.36 Million USD
|
-658.015%
|
Krystal Biotech, Inc.
|
10.93 Million USD
|
2691.063%
|
Karyopharm Therapeutics Inc.
|
-143.09 Million USD
|
-97.943%
|
SpringWorks Therapeutics, Inc.
|
-325.1 Million USD
|
12.872%
|
Lipella Pharmaceuticals Inc.
|
-4.61 Million USD
|
-6032.434%
|
MannKind Corporation
|
-11.93 Million USD
|
-2272.717%
|
Ikena Oncology, Inc.
|
-68.16 Million USD
|
-315.537%
|
Cyclerion Therapeutics, Inc.
|
-21.01 Million USD
|
-1247.871%
|
Gyre Therapeutics, Inc.
|
-92.93 Million USD
|
-204.795%
|
Gossamer Bio, Inc.
|
-179.81 Million USD
|
-57.524%
|
CohBar, Inc.
|
-11.96 Million USD
|
-2267.933%
|
Cognition Therapeutics, Inc.
|
-25.78 Million USD
|
-998.398%
|
NRx Pharmaceuticals, Inc.
|
-30.15 Million USD
|
-839.486%
|
Legend Biotech Corporation
|
-518.25 Million USD
|
45.344%
|
Mural Oncology plc
|
-207.44 Million USD
|
-36.543%
|
Biora Therapeutics, Inc.
|
-124.11 Million USD
|
-128.22%
|
PaxMedica, Inc. Common Stock
|
-18.28 Million USD
|
-1448.711%
|
Disc Medicine, Inc.
|
-76.42 Million USD
|
-270.612%
|
Champions Oncology, Inc.
|
-7.27 Million USD
|
-3793.004%
|
REGENXBIO Inc.
|
-263.49 Million USD
|
-7.5%
|
Ensysce Biosciences, Inc.
|
-10.61 Million USD
|
-2568.925%
|
Anavex Life Sciences Corp.
|
-47.5 Million USD
|
-496.264%
|
Cellectar Biosciences, Inc.
|
-37.98 Million USD
|
-645.732%
|
Edgewise Therapeutics, Inc.
|
-100.16 Million USD
|
-182.794%
|
Vaxart, Inc.
|
-82.46 Million USD
|
-243.485%
|
PharmaCyte Biotech, Inc.
|
333.76 Thousand USD
|
84967.106%
|
Aldeyra Therapeutics, Inc.
|
-37.54 Million USD
|
-654.491%
|
Cellectis S.A.
|
-101.05 Million USD
|
-180.287%
|
Longeveron Inc.
|
-21.41 Million USD
|
-1222.818%
|
Repare Therapeutics Inc.
|
-93.79 Million USD
|
-201.99%
|
Sarepta Therapeutics, Inc.
|
-535.97 Million USD
|
47.152%
|
Inozyme Pharma, Inc.
|
-71.16 Million USD
|
-298.003%
|
Revolution Medicines, Inc.
|
-436.36 Million USD
|
35.088%
|
Nymox Pharmaceutical Corporation
|
-6.57 Million USD
|
-4210.683%
|
Third Harmonic Bio, Inc.
|
-30.82 Million USD
|
-818.943%
|
ArriVent BioPharma, Inc. Common Stock
|
-69.33 Million USD
|
-308.543%
|
AN2 Therapeutics, Inc.
|
-64.73 Million USD
|
-337.581%
|
Anixa Biosciences, Inc.
|
-9.81 Million USD
|
-2787.117%
|
Vertex Pharmaceuticals Incorporated
|
3.61 Billion USD
|
107.826%
|
Denali Therapeutics Inc.
|
-145.22 Million USD
|
-95.047%
|
Revelation Biosciences, Inc.
|
-120.25 Thousand USD
|
-235447.258%
|
Veru Inc.
|
-93.15 Million USD
|
-204.076%
|
Corvus Pharmaceuticals, Inc.
|
-27.02 Million USD
|
-947.967%
|
Cingulate Inc.
|
-23.53 Million USD
|
-1103.551%
|
Passage Bio, Inc.
|
-102.06 Million USD
|
-177.532%
|
Context Therapeutics Inc.
|
-23.96 Million USD
|
-1081.992%
|
Exicure, Inc.
|
-16.91 Million USD
|
-1574.678%
|
Day One Biopharmaceuticals, Inc.
|
-188.91 Million USD
|
-49.936%
|
Oramed Pharmaceuticals Inc.
|
-37.76 Million USD
|
-650.066%
|
Revolution Medicines, Inc. Warrant
|
-436.36 Million USD
|
35.088%
|
Scinai Immunotherapeutics Ltd.
|
-6.5 Million USD
|
-4252.864%
|
Rhythm Pharmaceuticals, Inc.
|
-184.67 Million USD
|
-53.378%
|
Nuvalent, Inc.
|
-126.21 Million USD
|
-124.416%
|
ABVC BioPharma, Inc.
|
-10.51 Million USD
|
-2593.65%
|
Carisma Therapeutics, Inc.
|
-86.87 Million USD
|
-226.034%
|
Unicycive Therapeutics, Inc.
|
-30.54 Million USD
|
-827.367%
|
OmniAb, Inc.
|
-50.61 Million USD
|
-459.582%
|
Anew Medical, Inc.
|
1.34 Million USD
|
21142.251%
|
Fennec Pharmaceuticals Inc.
|
-16.04 Million USD
|
-1665.379%
|
Lipocine Inc.
|
-16.35 Million USD
|
-1632.226%
|
Lexeo Therapeutics, Inc. Common Stock
|
-66.39 Million USD
|
-326.627%
|
Nautilus Biotechnology, Inc.
|
-63.67 Million USD
|
-344.845%
|
SAB Biotherapeutics, Inc.
|
-42.19 Million USD
|
-571.319%
|
G1 Therapeutics, Inc.
|
-47.96 Million USD
|
-490.521%
|
Bellerophon Therapeutics, Inc.
|
-19.83 Million USD
|
-1328.345%
|
Sage Therapeutics, Inc.
|
-541.48 Million USD
|
47.69%
|
Ocugen, Inc.
|
-63.07 Million USD
|
-349.055%
|
Mind Medicine (MindMed) Inc.
|
-95.73 Million USD
|
-195.883%
|
Q32 Bio Inc.
|
-112.96 Million USD
|
-150.755%
|
Brainstorm Cell Therapeutics Inc.
|
-17.19 Million USD
|
-1547.598%
|
Alumis Inc. Common Stock
|
-154.99 Million USD
|
-82.753%
|
Equillium, Inc.
|
-13.33 Million USD
|
-2024.147%
|
Kyverna Therapeutics, Inc.
|
-60.36 Million USD
|
-369.229%
|
Coya Therapeutics, Inc.
|
-7.98 Million USD
|
-3446.079%
|
CNS Pharmaceuticals, Inc.
|
-18.85 Million USD
|
-1402.581%
|
Galera Therapeutics, Inc.
|
-59.08 Million USD
|
-379.427%
|
Evelo Biosciences, Inc.
|
-114.52 Million USD
|
-147.326%
|
Comera Life Sciences Holdings, Inc.
|
-18.37 Million USD
|
-1441.276%
|
Dominari Holdings Inc.
|
-22.88 Million USD
|
-1137.894%
|
Edesa Biotech, Inc.
|
-8.37 Million USD
|
-3282.386%
|
vTv Therapeutics Inc.
|
-20.25 Million USD
|
-1298.79%
|
Bio-Techne Corporation
|
168.1 Million USD
|
268.499%
|
Agios Pharmaceuticals, Inc.
|
-352.08 Million USD
|
19.55%
|
Harmony Biosciences Holdings, Inc.
|
128.85 Million USD
|
319.828%
|
Prelude Therapeutics Incorporated
|
-121.83 Million USD
|
-132.496%
|
Candel Therapeutics, Inc.
|
-37.93 Million USD
|
-646.606%
|
iTeos Therapeutics, Inc.
|
-112.64 Million USD
|
-151.465%
|
Nkarta, Inc.
|
-117.5 Million USD
|
-141.066%
|
BioCardia, Inc.
|
-11.57 Million USD
|
-2347.973%
|
Iterum Therapeutics plc
|
-38.37 Million USD
|
-638.201%
|